Actionable news
All posts from Actionable news
Actionable news in KERX: Keryx Biopharmaceuticals, Inc.,

Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Keryx Biopharmaceuticals ( KERX) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Keryx Biopharmaceuticals as such a stock due to the following factors:

  • KERX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $17.7 million.
  • KERX has traded 2.1 million shares today.
  • KERX is down 3.1% today.
  • KERX was up 12.3% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in KERX with the Ticky from Trade-Ideas. See the FREE profile for KERX NOW at Trade-Ideas More details on KERX: Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Currently there are 6 analysts that rate Keryx Biopharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Keryx Biopharmaceuticals has been 2.3 million shares per day over the past 30 days. Keryx has a market cap of $454.3 million and is part of the health care sector and drugs industry. The stock has a beta of 6.44 and a short float of 44.7% with 9.89 days to cover. Shares are down 65.7% year-to-date...